CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
552
|
2 |
HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
511
|
0 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
409
|
25 |
DMD |
P11532
|
dystrophin
|
|
1.00 |
0.423 |
0.923 |
360
|
36 |
JAG1 |
P78504
|
jagged canonical Notch ligand 1
|
|
1.00 |
0.429 |
0.808 |
322
|
5 |
PML |
P29590
|
promyelocytic leukemia
|
|
0.21 |
0.477 |
0.846 |
210
|
5 |
PAX5 |
Q02548
|
paired box 5
|
|
1.00 |
0.487 |
0.654 |
191
|
9 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
165
|
2 |
BCAR1 |
P56945
|
BCAR1 scaffold protein, Cas family member
|
|
1.00 |
0.518 |
0.846 |
163
|
1 |
UROD |
P06132
|
uroporphyrinogen decarboxylase
|
|
1.3E-08 |
0.521 |
0.769 |
146
|
6 |
TMX2-CTNND1 |
|
TMX2-CTNND1 readthrough (NMD candidate)
|
|
|
0.538 |
0.769 |
138
|
2 |
RTL1 |
A6NKG5
|
retrotransposon Gag like 1
|
|
5.6E-03 |
0.554 |
0.808 |
117
|
0 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
105
|
2 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
96
|
0 |
IGHV1-12 |
|
immunoglobulin heavy variable 1-12 (pseudogene)
|
|
|
0.569 |
0.654 |
89
|
0 |
SETBP1 |
Q9Y6X0
|
SET binding protein 1
|
|
1.00 |
0.503 |
0.808 |
81
|
1 |
PEG10 |
Q86TG7
|
paternally expressed 10
|
|
0.87 |
0.597 |
0.615 |
75
|
0 |
SMC1A |
Q14683
|
structural maintenance of chromosomes 1A
|
|
1.00 |
0.509 |
0.808 |
69
|
1 |
PAX1 |
P15863
|
paired box 1
|
|
0.70 |
0.593 |
0.654 |
57
|
1 |
ENDOU |
P21128
|
endonuclease, poly(U) specific
|
|
3.2E-14 |
0.682 |
0.423 |
41
|
0 |
MOGS |
Q13724
|
mannosyl-oligosaccharide glucosidase
|
|
5.8E-11 |
0.626 |
0.731 |
38
|
3 |
DLEU7 |
Q6UYE1
|
deleted in lymphocytic leukemia 7
|
|
0.18 |
0.705 |
0.346 |
21
|
1 |
CRYBG1 |
Q9Y4K1
|
crystallin beta-gamma domain containing 1
|
|
3.5E-33 |
0.743 |
0.462 |
18
|
1 |
XIC |
|
X chromosome inactivation center
|
|
|
0.821 |
0.462 |
9
|
0 |